Cell therapy investors

6 investors that name Cell therapy among their sectors are recorded here: 5 venture capital firms and 1 asset manager. Stated investment stages run from pre-seed to Series B. Most are headquartered in the United States (3), Israel (1) and the Netherlands (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.